BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30882726)

  • 41. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resurgence of Pertussis and Emergence of the Ptxp3 Toxin Promoter Allele in South Italy.
    Loconsole D; De Robertis AL; Morea A; Metallo A; Lopalco PL; Chironna M
    Pediatr Infect Dis J; 2018 May; 37(5):e126-e131. PubMed ID: 28945679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges and prospects in treating macrolide-resistant Bordetella pertussis in Chinese paediatric practice.
    Yang R; Xu H; Zhang Z; Liu Q; Wu X
    J Infect; 2024 Jul; 89(1):106185. PubMed ID: 38763390
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.
    van Gent M; Heuvelman CJ; van der Heide HG; Hallander HO; Advani A; Guiso N; Wirsing von Kőnig CH; Vestrheim DF; Dalby T; Fry NK; Pierard D; Detemmerman L; Zavadilova J; Fabianova K; Logan C; Habington A; Byrne M; Lutyńska A; Mosiej E; Pelaz C; Gröndahl-Yli-Hannuksela K; Barkoff AM; Mertsola J; Economopoulou A; He Q; Mooi FR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):821-30. PubMed ID: 25527446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-infection with two different strains of Bordetella pertussis in an infant.
    Cassiday PK; Tobin-D'Angelo M; Watson JR; Wu KH; Park MM; Sanden GN
    J Med Microbiol; 2008 Mar; 57(Pt 3):388-391. PubMed ID: 18287306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004.
    Advani A; Donnelly D; Gustafsson L; Hallander HO
    APMIS; 2007 Apr; 115(4):299-310. PubMed ID: 17504296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
    Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
    J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
    Carriquiriborde F; Regidor V; Aispuro PM; Magali G; Bartel E; Bottero D; Hozbor D
    Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Population diversity among Bordetella pertussis isolates, United States, 1935-2009.
    Schmidtke AJ; Boney KO; Martin SW; Skoff TH; Tondella ML; Tatti KM
    Emerg Infect Dis; 2012 Aug; 18(8):1248-55. PubMed ID: 22841154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemic of erythromycin-resistant
    Yao K; Deng J; Ma X; Dai W; Chen Q; Zhou K; Ye J; Shi W; Wang H; Li D; Wang H; Wang J; Zhang J; Wu D; Xie G; Shen K; Zheng Y; Yang Y
    Expert Rev Vaccines; 2020 Nov; 19(11):1093-1099. PubMed ID: 33034224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.
    Octavia S; Sintchenko V; Gilbert GL; Lawrence A; Keil AD; Hogg G; Lan R
    J Infect Dis; 2012 Apr; 205(8):1220-4. PubMed ID: 22416243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997.
    Lin YC; Yao SM; Yan JJ; Chen YY; Hsiao MJ; Chou CY; Su HP; Wu HS; Li SY
    Microbes Infect; 2006 Jul; 8(8):2082-7. PubMed ID: 16828571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
    Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
    Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
    Langley JM; Halperin SA; Boucher FD; Smith B;
    Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular epidemiology of the pertussis epidemic in Washington State in 2012.
    Bowden KE; Williams MM; Cassiday PK; Milton A; Pawloski L; Harrison M; Martin SW; Meyer S; Qin X; DeBolt C; Tasslimi A; Syed N; Sorrell R; Tran M; Hiatt B; Tondella ML
    J Clin Microbiol; 2014 Oct; 52(10):3549-57. PubMed ID: 25031439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.
    Packard ER; Parton R; Coote JG; Fry NK
    J Med Microbiol; 2004 May; 53(Pt 5):355-365. PubMed ID: 15096543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic diversity and population dynamics of Bordetella pertussis in China between 1950-2007.
    Xu Y; Zhang L; Tan Y; Wang L; Zhang S; Wang J
    Vaccine; 2015 Nov; 33(46):6327-31. PubMed ID: 26409140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular epidemiology of Bordetella pertussis in Cambodia determined by direct genotyping of clinical specimens.
    Moriuchi T; Vichit O; Vutthikol Y; Hossain MS; Samnang C; Toda K; Grabovac V; Hiramatsu Y; Otsuka N; Shibayama K; Kamachi K
    Int J Infect Dis; 2017 Sep; 62():56-58. PubMed ID: 28751008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.